Chiral phosphine ligands

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.855-38-9,Tris(4-methoxyphenyl)phosphine,as a common compound, the synthetic route is as follows.,855-38-9

Using PHEMA-TX-1 as catalyst, the tris(4-methoxyphenyl)phosphane(1a) was transformed into tris(4-methoxyphenyl)phosphineoxide (2a) (Scheme 6). Typically, 1a (352 mg, 1.0 mmol), PHEMA-TX-1(0.52 mg, 0.001 mmol, 19 muL stock solution prepared by dissolving 56 mg PHEMA-TX-1 in 2.0 mL of DMF), CH3OH (30 mL) were addedinto to a 100 mL round bottom flask equipped with a magnetic stirrer.The reaction was triggered by irradiation of a 23W house hold lamp at room temperature under air atmosphere. The photocatalytic reaction was monitored by TLC (eluent: petroleum ether/ethyl acetate=20/1)and finished after 8 h. The solution was concentrated under vacuum and the mixture was again dissolved in 5 mL of ethyl acetate (EA). ThePHEMA-TX-1 was precipitated in EA and recovered for the second cycle of photocatalytic reaction. The NMR yield of 2a in the first cycle was 99% as determined by 1H NMR analysis of the crude reaction mixtureusing dibromomethane as internal standard. Subsequently, using the recovered PHEMA-TX-1 as catalyst, the following cycles of reactionswere performed using the same procedure as above. The result wasshown in Scheme 6. 1H NMR (400 MHz, CDCl3) delta 7.57 (dd, J=9.4,9.4 Hz, 6H), 6.95 (d, J=8.0 Hz, 6H), 3.83 (s, 9H).

The synthetic route of 855-38-9 has been constantly updated, and we look forward to future research findings.

Reference£º
Article; Ding, Aishun; Chen, Yang; Wang, Guowei; Zhang, Yaopeng; Hu, Jianhua; Guo, Hao; Polymer; vol. 174; (2019); p. 101 – 108;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.719-80-2,Ethoxydiphenylphosphine,as a common compound, the synthetic route is as follows.

719-80-2, Ethyl diphenylphosphinite,0.87 g (0.0038 mol), was added dropwise to asolution of 1.25 g (0.0038 mol) of compound 21a in1 mL of diethyl ether on cooling to -5 to 5C. Themixture was left to stand for 24 h at room temperature,and the solvent and volatile components were removedunder reduced pressure. Yield 1.44 g (76.6%), colorlesscrystals, mp 146-148C (from isooctane). The spectralcharacteristics of samples of 23a synthesized bydifferent methods were identical.

The synthetic route of 719-80-2 has been constantly updated, and we look forward to future research findings.

Reference£º
Article; Gazizov; Ivanova, S. Yu.; Khairullin; Kirillina, Yu. S.; Gazizova; Russian Journal of General Chemistry; vol. 88; 11; (2018); p. 2243 – 2250; Zh. Obshch. Khim.; vol. 88; 11; (2018); p. 1761 – 1769,9;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.6372-42-5,Cyclohexyldiphenylphosphine,as a common compound, the synthetic route is as follows.,6372-42-5

0.86 g (2.30×10″3 moles) of trichlorotris(tetrahydrofuran)vanadium [VCI3(THF)3], 20 ml of toluene and, subsequently, 2.40 g (9.0×10″3 moles) of dipheny(cyclohexyl)phosphine (P/V molar ratio = 4) were placed into a 100 ml tailed flask. The mixture obtained was left, under vigorous stirring, at room temperature, for 60 minutes and, then, heated under reflux for 1 hour. The suspension obtained was filtered in the hot (60C) and the fraction collected was concentrated, under vacuum, at room temperature. Subsequently, drop by drop, under stirring, about 50 ml of pentane were added, obtaining the precipitation of a dark powder. After about 3 hours, everything was filtered and the solid light blue/gray residue obtained was washed with pentane (50 ml) and dried, under vacuum, at room temperature, obtaining 1.30 g (conversion with respect to starting [VCI3(THF)3] = 81.4%) of complex VCI3(PCyPh2)2 (molecular weight = 693.97 gxmol”1). (0157) Elementary analysis [found (calculated)] C: 62.40% (62.31%); H: 6.30% (6.10%); CI: 15.50% (15.33%); P: 9.0% (8.93%); V: 7.20% (7.34%)

As the paragraph descriping shows that 6372-42-5 is playing an increasingly important role.

Reference£º
Patent; VERSALIS S.P.A.; RICCI, Giovanni; LEONE, Giuseppe; SOMMAZZI, Anna; FORNI, Alessandra; MASI, Francesco; (110 pag.)WO2016/128812; (2016); A1;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.24171-89-9,Tri(thiophen-2-yl)phosphine,as a common compound, the synthetic route is as follows.

To a solution of the chloro derivative of pyridoxine 9 (1 equiv) in 30 ml of acetonitrile were added trisubstituted phosphine (1-5 equiv). The reaction mixture was refluxed for 7 h. Different workup procedures were used for preparation of phosphonium salts., 24171-89-9

As the paragraph descriping shows that 24171-89-9 is playing an increasingly important role.

Reference£º
Article; Pugachev, Mikhail V.; Shtyrlin, Nikita V.; Sapozhnikov, Sergey V.; Sysoeva, Lubov P.; Iksanova, Alfiya G.; Nikitina, Elena V.; Musin, Rashid Z.; Lodochnikova, Olga A.; Berdnikov, Eugeny A.; Shtyrlin, Yurii G.; Bioorganic and Medicinal Chemistry; vol. 21; 23; (2013); p. 7330 – 7342;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.13440-07-8,Di(naphthalen-1-yl)phosphine oxide,as a common compound, the synthetic route is as follows.

Add 4-methoxycarbonylphenylacetylene to the reaction flask(0.080 g, 0.5 mmol), dinaphthylphosphoric acid(0.30 g, 1 mmol), CuBr (0.014 g, 0.1 mmol),Di-tert-butyl peroxide (0.30 g, 2 mmol),Reacts with water (2 mL) at 80oC;TLC tracks the reaction until it is completely over;The crude product obtained after the completion of the reaction was separated by column chromatography (ethyl acetate: petroleum ether = 1:1) to give the desired product.(Yield 75%)., 13440-07-8

As the paragraph descriping shows that 13440-07-8 is playing an increasingly important role.

Reference£º
Patent; Nantong Textile Silk Industrial Technology Institute; Soochow University (Suzhou); Zou Jianping; Tao Zekun; Lv Shuaishuai; Li Chengkun; Li Jianan; (12 pag.)CN109096336; (2018); A;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.12150-46-8,1,1-Bis(diphenylphosphino)ferrocene,as a common compound, the synthetic route is as follows.

General procedure: A dichloromethane solution of [Fe3(mu3-YTe)(CO)9] {Y = S (1), Se(2), Te(3)} (0.1 mmol) was reacted with bis-(diphenylphosphino) ferrocene (55 mg, 0.1 mmol) at room temperature under continuous stirring condition and nitrogen atmosphere for 3 h. The reaction was monitored by TLC. On completion of the reaction the solution was dried under vacuum and the residue was dissolved in dichloromethane solvent and subjected to chromatographic work-up using preparative TLC. Elution with dichloromethane/hexane (30:70 v/v) solvent mixture separated a red compound, [Fe3YTe(CO)8{eta2-(PPh2)(C5H4)Fe(C5H4)(PPh2)}] {Y = S (8), Se(9), Te(10)} (Yields = 62 mg, 56percent (8), 70 mg, 61percent (9), 86 mg, 72percent (10)) along with unreacted [Fe3YTe(CO)9] and trace amount of a black product and decomposition during the work-up.

12150-46-8, The synthetic route of 12150-46-8 has been constantly updated, and we look forward to future research findings.

Reference£º
Article; Tirkey, Vijaylakshmi; Boddhula, Rajkumar; Mishra, Sasmita; Mobin, Shaikh M.; Chatterjee, Saurav; Journal of Organometallic Chemistry; vol. 794; (2015); p. 88 – 95;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.50777-76-9,2-(Diphenylphosphino)benzaldehyde,as a common compound, the synthetic route is as follows.

General procedure: To a solution of (mu-SCH2CH2S-mu)Fe2(CO)6 (0.074g, 0.2mmol) and tris(4-fluorophenyl)phosphine (0.063g, 0.2mmol) in CH2Cl2 (10mL) was added a solution of Me3NO¡¤2H2O (0.026g, 0.23mmol) in MeCN. The mixture was stirred at room temperature for 1h and then the solvent was reduced in vacuo and the residue was subjected to TLC separation using CH2Cl2/ petroleum ether (v/v=1:2) as eluent. From the main red band, 0.111g (84percent) of complex 1 was obtained as a red solid., 50777-76-9

The synthetic route of 50777-76-9 has been constantly updated, and we look forward to future research findings.

Reference£º
Article; Liu, Xu-Feng; Polyhedron; vol. 119; (2016); p. 71 – 76;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.18437-78-0,Tris(4-fluorophenyl)phosphine,as a common compound, the synthetic route is as follows.

To a solution of (mu-SCH2CH2S-mu)Fe2(CO)6 (0.074g, 0.2mmol) and tris(4-fluorophenyl)phosphine (0.063g, 0.2mmol) in CH2Cl2 (10mL) was added a solution of Me3NO¡¤2H2O (0.026g, 0.23mmol) in MeCN. The mixture was stirred at room temperature for 1h and then the solvent was reduced in vacuo and the residue was subjected to TLC separation using CH2Cl2/ petroleum ether (v/v=1:2) as eluent. From the main red band, 0.111g (84percent) of complex 1 was obtained as a red solid. IR (KBr disk, cm?1): nuC?O 2052 (vs), 1983 (vs), 1976 (vs), 1937 (vs). 1H NMR (500MHz, CDCl3): 7.55?7.50 (m, 6H, PhH), 7.14 (t, J=8Hz, 6H, PhH), 1.93 (d, J=7Hz, 2H, SCH2), 1.19 (d, J=8Hz, 2H, SCH2) ppm. 31P{1H} NMR (200MHz, CDCl3, 85percent H3PO4): 61.45 (s) ppm. 13C{1H} NMR (125MHz, CDCl3): 214.52 (d, JP-C=8.4Hz, PFeCO), 209.66 (FeCO), 164.92, 162.91 (dd, JP-C=1.4Hz, JF-C=251.7Hz, p-PhC), 135.13, 134.03 (dd, JP-C=8.4Hz, JF-C=13.1Hz, o-PhC), 131.67, 131.34 (dd, JP-C=40.7Hz, JF-C=3.4Hz, i-PhC), 116.21, 116.05 (dd, JP-C=10.6Hz, JF-C=21Hz, m-PhC), 34.88 (d, JP-C=2.9Hz, SCH2) ppm. Anal. Calc. for C25H16F3Fe2O5PS2: C, 45.48; H, 2.44. Found: C, 45.54; H, 2.56., 18437-78-0

18437-78-0 Tris(4-fluorophenyl)phosphine 140387, achiral-phosphine-ligands compound, is more and more widely used in various fields.

Reference£º
Article; Liu, Xu-Feng; Polyhedron; vol. 119; (2016); p. 71 – 76;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.29949-84-6,Tris(3-methoxyphenyl)phosphine,as a common compound, the synthetic route is as follows.

General procedure: A. TfOCH2CF2H(0.514 g, 2.4 mmol) and triphenylphosphine (0.525 g, 2 mmol) were placed in aclosed Schlenk flask under a N2 atmosphere. The mixture was stirredat 120 oC for 24 h and cooled to room temperature. The resultingsolid was washed by diethyl ether, recrystallized from CH2Cl2/hexane,and dried in vacuum to give 0.66 g of (E)-ethene-1,2-diylbis(triphenylphosphonium)ditriflate (3a) as a white solid (0.78 mmol, 78%).2

29949-84-6, The synthetic route of 29949-84-6 has been constantly updated, and we look forward to future research findings.

Reference£º
Article; Wang, Shi-Meng; Han, Jia-Bin; Zhang, Cheng-Pan; Qin, Hua-Li; Tetrahedron Letters; vol. 56; 45; (2015); p. 6219 – 6222;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

6737-42-4, 1,3-Bis(diphenylphosphino)propane is a chiral-phosphine-ligands compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

6737-42-4, (c) Methyl 3,4-dimethoxy-1-naphthalenecarboxylate A solution of 1-bromo-3,4-dimethoxylnaphthalene (3.72 g, 13.9 mmol), 1,3-bis(diphenylphosphino)propane (0.29 g, 0.7 mmol), palladium acetate (0.16 g, 0.70 mmol), triethylamine (4.85 mL, 34.8 mmol), MeOH (11.5 mL) and DMSO (17 mL) was heated to 75 C. Carbon monoxide was bubbled through the solution for 30 min and the mixture heated under CO (1 atm) for 23 h. The mixture was diluted with brine and extracted with EtOAc (3*70 mL). The organic layers were dried (MgSO4), filtered, and concentrated. Column chromatography gave methyl 3,4-dimethoxy-1-naphthalenecarboxylate as a yellow oil (2.93 g, 85%). 1H NMR (CDCl3) delta 8.89 (m, 1H), 8.21 (m, 1H), 8.06 (s, 1H), 7.52 (m, 2H), 4.06 (s, 3H), 4.02 (s, 3H), 4.00 (s, 3H); MS (APCI) m/z 247 (M+H).

The synthetic route of 6737-42-4 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; Astrazeneca AB; US6403601; (2002); B1;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate